Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.27B |
| 2 |
Zimmer Biomet
ZBH
|
+$3.42B |
| 3 |
TransUnion
TRU
|
+$1.8B |
| 4 |
Qualcomm
QCOM
|
+$587M |
| 5 |
Alibaba
BABA
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.06B |
| 2 |
Pfizer
PFE
|
+$895M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$631M |
| 4 |
RTX Corp
RTX
|
+$546M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.41% |
| 2 | Healthcare | 8.04% |
| 3 | Technology | 7.66% |
| 4 | Energy | 6.94% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
CALL
Corpay
CPAY
$25B
| $2.37M | ﹤0.01% |
15,200
-12,200
| -45% | -$1.91M |
|
3627
CALL
Marvell Technology
MRVL
$168B
| $2.37M | ﹤0.01% |
179,700
-126,400
| -41% | -$1.81M |
|
|
IRC
3628
DELISTED
INLAND REAL ESTATE CORP
IRC
| $2.37M | ﹤0.01% |
250,963
+65,373
| +35% | +$668K |
|
3629
CALL
Hershey
HSY
$35.2B
| $2.36M | ﹤0.01% |
26,600
-5,200
| -16% | -$490K |
|
|
WBMD
3630
DELISTED
WebMD Health Corp.
WBMD
| $2.36M | ﹤0.01% |
53,338
-13,725
| -20% | -$627K |
|
|
SFR
3631
DELISTED
Starwood Waypoint Homes
SFR
| $2.36M | ﹤0.01% |
99,434
+21,617
| +28% | +$553K |
|
3632
First Trust Financials AlphaDEX Fund
FXO
$1.13B
| $2.35M | ﹤0.01% |
+99,028
| New | +$2.37M |
|
3633
FTI Consulting
FCN
$4.4B
| $2.35M | ﹤0.01% |
56,975
+5,296
| +10% | +$211K |
|
|
XNPT
3634
PUT
DELISTED
XENOPORT, INC.
XNPT
| $2.35M | ﹤0.01% |
383,000
| – | – |
|
|
NUVA
3635
CALL
DELISTED
NuVasive, Inc.
NUVA
| $2.35M | ﹤0.01% |
+49,500
| New | +$2.31M |
|
|
NUVA
3636
PUT
DELISTED
NuVasive, Inc.
NUVA
| $2.35M | ﹤0.01% |
+49,500
| New | +$2.31M |
|
3637
Schwab Emerging Markets Equity ETF
SCHE
$12.6B
| $2.34M | ﹤0.01% |
+95,359
| New | +$2.44M |
|
3638
PUT
Invesco CurrencyShares British Pound Sterling Trust
FXB
$77.8M
| $2.34M | ﹤0.01% |
15,200
-16,000
| -51% | -$2.41M |
|
3639
CALL
Enbridge
ENB
$119B
| $2.34M | ﹤0.01% |
50,000
-379,000
| -88% | -$18.8M |
|
|
CBB
3640
DELISTED
Cincinnati Bell Inc.
CBB
| $2.34M | ﹤0.01% |
122,437
-2,172
| -2% | -$39.7K |
|
|
RYL
3641
PUT
DELISTED
RYLAND GROUP INC
RYL
| $2.34M | ﹤0.01% |
50,400
-34,700
| -41% | -$1.54M |
|
3642
CALL
NRG Energy
NRG
$28.3B
| $2.34M | ﹤0.01% |
102,100
-749,800
| -88% | -$18.7M |
|
3643
CALL
Neurocrine Biosciences
NBIX
$16.8B
| $2.33M | ﹤0.01% |
48,900
-100
| -0.2% | -$4.24K |
|
|
3644
PUT
Neurocrine Biosciences
NBIX
$16.8B
| $2.33M | ﹤0.01% |
48,900
-100
| -0.2% | -$4.24K |
|
3645
CALL
Puma Biotechnology
PBYI
$404M
| $2.33M | ﹤0.01% |
20,000
-15,300
| -43% | -$2.77M |
|
3646
Invesco S&P Spin-Off ETF
CSD
$221M
| $2.33M | ﹤0.01% |
50,883
+81
| +0.2% | +$3.87K |
|
3647
PUT
NetEase
NTES
$85.3B
| $2.33M | ﹤0.01% |
80,500
-67,000
| -45% | -$1.79M |
|
3648
CALL
Cracker Barrel
CBRL
$1.26B
| $2.33M | ﹤0.01% |
15,600
+5,600
| +56% | +$797K |
|
|
PPL
3649
CALL
PPL Corp
PPL
$26.5B
| $2.33M | ﹤0.01% |
78,900
+5,247
| +7% | +$164K |
|
|
AIXG
3650
DELISTED
Aixtron SE
AIXG
| $2.33M | ﹤0.01% |
345,001
+99,272
| +40% | +$739K |
|
Similar funds
Goldman Sachs's Q2 2015 Portfolio in Review
As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.
By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.
- Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
- Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
- Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
- Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
- Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
- Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.
Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.